nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—TEK—artery—uterine fibroid	0.0108	0.0177	CbGeAlD
Regorafenib—DDR2—myometrium—uterine fibroid	0.0107	0.0175	CbGeAlD
Regorafenib—NTRK1—decidua—uterine fibroid	0.0107	0.0175	CbGeAlD
Regorafenib—FLT1—artery—uterine fibroid	0.0105	0.0172	CbGeAlD
Regorafenib—KDR—artery—uterine fibroid	0.00886	0.0145	CbGeAlD
Regorafenib—DDR2—uterine cervix—uterine fibroid	0.00832	0.0136	CbGeAlD
Regorafenib—DDR2—smooth muscle tissue—uterine fibroid	0.00809	0.0132	CbGeAlD
Regorafenib—DDR2—decidua—uterine fibroid	0.00793	0.013	CbGeAlD
Regorafenib—DDR2—endometrium—uterine fibroid	0.00753	0.0123	CbGeAlD
Regorafenib—DDR2—mammalian vulva—uterine fibroid	0.00728	0.0119	CbGeAlD
Regorafenib—EPHX2—myometrium—uterine fibroid	0.00722	0.0118	CbGeAlD
Regorafenib—FRK—female reproductive system—uterine fibroid	0.00695	0.0114	CbGeAlD
Regorafenib—DDR2—uterus—uterine fibroid	0.00693	0.0113	CbGeAlD
Regorafenib—FGFR1—myometrium—uterine fibroid	0.00643	0.0105	CbGeAlD
Regorafenib—EPHA2—nipple—uterine fibroid	0.00626	0.0102	CbGeAlD
Regorafenib—DDR2—female reproductive system—uterine fibroid	0.00623	0.0102	CbGeAlD
Regorafenib—MAPK11—female reproductive system—uterine fibroid	0.00591	0.00967	CbGeAlD
Regorafenib—FLT1—nipple—uterine fibroid	0.0059	0.00966	CbGeAlD
Regorafenib—RAF1—nipple—uterine fibroid	0.00587	0.0096	CbGeAlD
Regorafenib—DDR2—female gonad—uterine fibroid	0.00567	0.00928	CbGeAlD
Regorafenib—DDR2—vagina—uterine fibroid	0.00564	0.00923	CbGeAlD
Regorafenib—MAPK11—female gonad—uterine fibroid	0.00538	0.0088	CbGeAlD
Regorafenib—EPHA2—myometrium—uterine fibroid	0.00537	0.00879	CbGeAlD
Regorafenib—BRAF—endometrium—uterine fibroid	0.00532	0.0087	CbGeAlD
Regorafenib—EPHX2—urethra—uterine fibroid	0.00516	0.00845	CbGeAlD
Regorafenib—FLT1—myometrium—uterine fibroid	0.00506	0.00829	CbGeAlD
Regorafenib—RAF1—myometrium—uterine fibroid	0.00503	0.00824	CbGeAlD
Regorafenib—FGFR1—uterine cervix—uterine fibroid	0.005	0.00818	CbGeAlD
Regorafenib—KDR—nipple—uterine fibroid	0.00499	0.00817	CbGeAlD
Regorafenib—EPHX2—mammalian vulva—uterine fibroid	0.00492	0.00805	CbGeAlD
Regorafenib—BRAF—uterus—uterine fibroid	0.0049	0.00802	CbGeAlD
Regorafenib—FLT4—decidua—uterine fibroid	0.00483	0.0079	CbGeAlD
Regorafenib—FGFR1—decidua—uterine fibroid	0.00476	0.0078	CbGeAlD
Regorafenib—EPHX2—uterus—uterine fibroid	0.00468	0.00766	CbGeAlD
Regorafenib—FGFR1—urethra—uterine fibroid	0.0046	0.00752	CbGeAlD
Regorafenib—KIT—nipple—uterine fibroid	0.00442	0.00724	CbGeAlD
Regorafenib—FGFR1—mammalian vulva—uterine fibroid	0.00437	0.00716	CbGeAlD
Regorafenib—PDGFRB—nipple—uterine fibroid	0.00432	0.00707	CbGeAlD
Regorafenib—KDR—myometrium—uterine fibroid	0.00428	0.00701	CbGeAlD
Regorafenib—RET—decidua—uterine fibroid	0.00426	0.00698	CbGeAlD
Regorafenib—FGFR2—uterine cervix—uterine fibroid	0.00425	0.00696	CbGeAlD
Regorafenib—FGFR1—cardiac atrium—uterine fibroid	0.00419	0.00686	CbGeAlD
Regorafenib—EPHA2—uterine cervix—uterine fibroid	0.00418	0.00684	CbGeAlD
Regorafenib—FGFR1—uterus—uterine fibroid	0.00417	0.00682	CbGeAlD
Regorafenib—FGFR2—smooth muscle tissue—uterine fibroid	0.00413	0.00676	CbGeAlD
Regorafenib—BRAF—female gonad—uterine fibroid	0.00401	0.00656	CbGeAlD
Regorafenib—BRAF—vagina—uterine fibroid	0.00399	0.00652	CbGeAlD
Regorafenib—EPHA2—decidua—uterine fibroid	0.00398	0.00651	CbGeAlD
Regorafenib—TEK—smooth muscle tissue—uterine fibroid	0.00396	0.00648	CbGeAlD
Regorafenib—FLT1—uterine cervix—uterine fibroid	0.00394	0.00645	CbGeAlD
Regorafenib—RAF1—uterine cervix—uterine fibroid	0.00392	0.00641	CbGeAlD
Regorafenib—TEK—decidua—uterine fibroid	0.00388	0.00636	CbGeAlD
Regorafenib—ABL1—nipple—uterine fibroid	0.00385	0.0063	CbGeAlD
Regorafenib—EPHA2—urethra—uterine fibroid	0.00384	0.00628	CbGeAlD
Regorafenib—EPHX2—female gonad—uterine fibroid	0.00383	0.00627	CbGeAlD
Regorafenib—FLT1—smooth muscle tissue—uterine fibroid	0.00383	0.00627	CbGeAlD
Regorafenib—EPHX2—vagina—uterine fibroid	0.00381	0.00623	CbGeAlD
Regorafenib—RAF1—smooth muscle tissue—uterine fibroid	0.00381	0.00623	CbGeAlD
Regorafenib—FLT4—female reproductive system—uterine fibroid	0.0038	0.00621	CbGeAlD
Regorafenib—KIT—myometrium—uterine fibroid	0.00379	0.00621	CbGeAlD
Regorafenib—EPHA2—endometrium—uterine fibroid	0.00378	0.00618	CbGeAlD
Regorafenib—FLT1—decidua—uterine fibroid	0.00375	0.00614	CbGeAlD
Regorafenib—TEK—urethra—uterine fibroid	0.00375	0.00613	CbGeAlD
Regorafenib—RAF1—decidua—uterine fibroid	0.00373	0.00611	CbGeAlD
Regorafenib—PDGFRB—myometrium—uterine fibroid	0.00371	0.00606	CbGeAlD
Regorafenib—TEK—endometrium—uterine fibroid	0.00369	0.00603	CbGeAlD
Regorafenib—EPHA2—mammalian vulva—uterine fibroid	0.00366	0.00598	CbGeAlD
Regorafenib—FLT1—urethra—uterine fibroid	0.00362	0.00593	CbGeAlD
Regorafenib—RAF1—urethra—uterine fibroid	0.0036	0.00589	CbGeAlD
Regorafenib—PDGFRA—smooth muscle tissue—uterine fibroid	0.00359	0.00587	CbGeAlD
Regorafenib—FLT1—endometrium—uterine fibroid	0.00356	0.00583	CbGeAlD
Regorafenib—RAF1—endometrium—uterine fibroid	0.00354	0.0058	CbGeAlD
Regorafenib—FGFR2—uterus—uterine fibroid	0.00354	0.0058	CbGeAlD
Regorafenib—PDGFRA—decidua—uterine fibroid	0.00352	0.00576	CbGeAlD
Regorafenib—EPHA2—cardiac atrium—uterine fibroid	0.0035	0.00573	CbGeAlD
Regorafenib—FLT4—female gonad—uterine fibroid	0.00346	0.00565	CbGeAlD
Regorafenib—FLT1—mammalian vulva—uterine fibroid	0.00345	0.00564	CbGeAlD
Regorafenib—RAF1—mammalian vulva—uterine fibroid	0.00343	0.00561	CbGeAlD
Regorafenib—TEK—cardiac atrium—uterine fibroid	0.00342	0.00559	CbGeAlD
Regorafenib—FGFR1—female gonad—uterine fibroid	0.00341	0.00558	CbGeAlD
Regorafenib—TEK—uterus—uterine fibroid	0.0034	0.00556	CbGeAlD
Regorafenib—FGFR1—vagina—uterine fibroid	0.00339	0.00554	CbGeAlD
Regorafenib—KDR—uterine cervix—uterine fibroid	0.00333	0.00545	CbGeAlD
Regorafenib—ABL1—myometrium—uterine fibroid	0.0033	0.0054	CbGeAlD
Regorafenib—FLT1—cardiac atrium—uterine fibroid	0.0033	0.0054	CbGeAlD
Regorafenib—FLT1—uterus—uterine fibroid	0.00328	0.00537	CbGeAlD
Regorafenib—RAF1—cardiac atrium—uterine fibroid	0.00328	0.00537	CbGeAlD
Regorafenib—RAF1—uterus—uterine fibroid	0.00327	0.00534	CbGeAlD
Regorafenib—KDR—smooth muscle tissue—uterine fibroid	0.00324	0.0053	CbGeAlD
Regorafenib—FGFR2—female reproductive system—uterine fibroid	0.00319	0.00521	CbGeAlD
Regorafenib—KDR—decidua—uterine fibroid	0.00317	0.00519	CbGeAlD
Regorafenib—EPHA2—female reproductive system—uterine fibroid	0.00313	0.00512	CbGeAlD
Regorafenib—PDGFRA—uterus—uterine fibroid	0.00308	0.00504	CbGeAlD
Regorafenib—KDR—urethra—uterine fibroid	0.00306	0.00501	CbGeAlD
Regorafenib—TEK—female reproductive system—uterine fibroid	0.00305	0.005	CbGeAlD
Regorafenib—KDR—endometrium—uterine fibroid	0.00301	0.00493	CbGeAlD
Regorafenib—FLT1—female reproductive system—uterine fibroid	0.00295	0.00483	CbGeAlD
Regorafenib—KIT—uterine cervix—uterine fibroid	0.00295	0.00483	CbGeAlD
Regorafenib—RAF1—female reproductive system—uterine fibroid	0.00294	0.0048	CbGeAlD
Regorafenib—KDR—mammalian vulva—uterine fibroid	0.00291	0.00477	CbGeAlD
Regorafenib—FGFR2—female gonad—uterine fibroid	0.0029	0.00474	CbGeAlD
Regorafenib—PDGFRB—uterine cervix—uterine fibroid	0.00288	0.00472	CbGeAlD
Regorafenib—KIT—smooth muscle tissue—uterine fibroid	0.00287	0.0047	CbGeAlD
Regorafenib—EPHA2—female gonad—uterine fibroid	0.00285	0.00466	CbGeAlD
Regorafenib—EPHA2—vagina—uterine fibroid	0.00283	0.00463	CbGeAlD
Regorafenib—KIT—decidua—uterine fibroid	0.00281	0.0046	CbGeAlD
Regorafenib—PDGFRB—smooth muscle tissue—uterine fibroid	0.0028	0.00459	CbGeAlD
Regorafenib—KDR—cardiac atrium—uterine fibroid	0.00279	0.00457	CbGeAlD
Regorafenib—TEK—female gonad—uterine fibroid	0.00278	0.00455	CbGeAlD
Regorafenib—KDR—uterus—uterine fibroid	0.00278	0.00454	CbGeAlD
Regorafenib—PDGFRA—female reproductive system—uterine fibroid	0.00277	0.00453	CbGeAlD
Regorafenib—PDGFRB—decidua—uterine fibroid	0.00275	0.0045	CbGeAlD
Regorafenib—KIT—urethra—uterine fibroid	0.00271	0.00444	CbGeAlD
Regorafenib—FLT1—female gonad—uterine fibroid	0.00269	0.0044	CbGeAlD
Regorafenib—RAF1—female gonad—uterine fibroid	0.00267	0.00437	CbGeAlD
Regorafenib—FLT1—vagina—uterine fibroid	0.00267	0.00437	CbGeAlD
Regorafenib—KIT—endometrium—uterine fibroid	0.00267	0.00437	CbGeAlD
Regorafenib—RAF1—vagina—uterine fibroid	0.00266	0.00434	CbGeAlD
Regorafenib—PDGFRB—urethra—uterine fibroid	0.00265	0.00434	CbGeAlD
Regorafenib—PDGFRB—endometrium—uterine fibroid	0.00261	0.00427	CbGeAlD
Regorafenib—KIT—mammalian vulva—uterine fibroid	0.00258	0.00423	CbGeAlD
Regorafenib—ABL1—uterine cervix—uterine fibroid	0.00257	0.00421	CbGeAlD
Regorafenib—PDGFRB—mammalian vulva—uterine fibroid	0.00252	0.00413	CbGeAlD
Regorafenib—PDGFRA—female gonad—uterine fibroid	0.00252	0.00412	CbGeAlD
Regorafenib—PDGFRA—vagina—uterine fibroid	0.0025	0.00409	CbGeAlD
Regorafenib—ABL1—smooth muscle tissue—uterine fibroid	0.0025	0.00409	CbGeAlD
Regorafenib—KDR—female reproductive system—uterine fibroid	0.0025	0.00408	CbGeAlD
Regorafenib—KIT—uterus—uterine fibroid	0.00246	0.00403	CbGeAlD
Regorafenib—ABL1—decidua—uterine fibroid	0.00245	0.00401	CbGeAlD
Regorafenib—PDGFRB—cardiac atrium—uterine fibroid	0.00242	0.00395	CbGeAlD
Regorafenib—PDGFRB—uterus—uterine fibroid	0.0024	0.00393	CbGeAlD
Regorafenib—ABL1—urethra—uterine fibroid	0.00236	0.00386	CbGeAlD
Regorafenib—ABL1—endometrium—uterine fibroid	0.00232	0.0038	CbGeAlD
Regorafenib—KDR—female gonad—uterine fibroid	0.00227	0.00372	CbGeAlD
Regorafenib—KDR—vagina—uterine fibroid	0.00226	0.00369	CbGeAlD
Regorafenib—ABL1—mammalian vulva—uterine fibroid	0.00225	0.00368	CbGeAlD
Regorafenib—KIT—female reproductive system—uterine fibroid	0.00221	0.00362	CbGeAlD
Regorafenib—PDGFRB—female reproductive system—uterine fibroid	0.00216	0.00354	CbGeAlD
Regorafenib—ABL1—cardiac atrium—uterine fibroid	0.00215	0.00352	CbGeAlD
Regorafenib—ABL1—uterus—uterine fibroid	0.00214	0.00351	CbGeAlD
Regorafenib—ABCG2—myometrium—uterine fibroid	0.00208	0.00341	CbGeAlD
Regorafenib—KIT—female gonad—uterine fibroid	0.00201	0.00329	CbGeAlD
Regorafenib—KIT—vagina—uterine fibroid	0.002	0.00327	CbGeAlD
Regorafenib—PDGFRB—female gonad—uterine fibroid	0.00197	0.00322	CbGeAlD
Regorafenib—PDGFRB—vagina—uterine fibroid	0.00195	0.0032	CbGeAlD
Regorafenib—ABL1—female reproductive system—uterine fibroid	0.00193	0.00315	CbGeAlD
Regorafenib—ABL1—female gonad—uterine fibroid	0.00175	0.00287	CbGeAlD
Regorafenib—EPHX2—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.00175	0.00449	CbGpPWpGaD
Regorafenib—ABL1—vagina—uterine fibroid	0.00174	0.00285	CbGeAlD
Regorafenib—FGFR1—Downstream signal transduction—TNRC6B—uterine fibroid	0.00172	0.00443	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00172	0.00442	CbGpPWpGaD
Regorafenib—PDGFRA—Downstream signal transduction—TNRC6B—uterine fibroid	0.00172	0.00442	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by FGFR—TNRC6B—uterine fibroid	0.00171	0.00441	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00171	0.0044	CbGpPWpGaD
Regorafenib—FGFR2—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00171	0.0044	CbGpPWpGaD
Regorafenib—FGFR2—DAP12 interactions—TNRC6B—uterine fibroid	0.00171	0.0044	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by FGFR—TNRC6B—uterine fibroid	0.00171	0.00439	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by ERBB2—TNRC6B—uterine fibroid	0.0017	0.00438	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by ERBB2—TNRC6B—uterine fibroid	0.0017	0.00437	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by EGFR—TNRC6B—uterine fibroid	0.0017	0.00436	CbGpPWpGaD
Regorafenib—FGFR1—DAP12 signaling—TNRC6B—uterine fibroid	0.0017	0.00436	CbGpPWpGaD
Regorafenib—PDGFRA—DAP12 signaling—TNRC6B—uterine fibroid	0.00169	0.00435	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00168	0.00433	CbGpPWpGaD
Regorafenib—KIT—DAP12 interactions—TNRC6B—uterine fibroid	0.00168	0.00433	CbGpPWpGaD
Regorafenib—KIT—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00168	0.00433	CbGpPWpGaD
Regorafenib—KIT—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00168	0.00433	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by PDGF—TNRC6B—uterine fibroid	0.00167	0.00431	CbGpPWpGaD
Regorafenib—FGFR1—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00167	0.0043	CbGpPWpGaD
Regorafenib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00167	0.00429	CbGpPWpGaD
Regorafenib—KIT—Signaling by EGFR—TNRC6B—uterine fibroid	0.00167	0.00429	CbGpPWpGaD
Regorafenib—KIT—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00165	0.00425	CbGpPWpGaD
Regorafenib—MAPK11—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00165	0.00425	CbGpPWpGaD
Regorafenib—PDGFRB—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00165	0.00423	CbGpPWpGaD
Regorafenib—KIT—Signaling by PDGF—TNRC6B—uterine fibroid	0.00164	0.00423	CbGpPWpGaD
Regorafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00164	0.00423	CbGpPWpGaD
Regorafenib—BRAF—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00164	0.00421	CbGpPWpGaD
Regorafenib—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00162	0.00417	CbGpPWpGaD
Regorafenib—ABCG2—uterine cervix—uterine fibroid	0.00162	0.00265	CbGeAlD
Regorafenib—PDGFRB—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00162	0.00417	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—MED12—uterine fibroid	0.00162	0.00416	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by ERBB4—PGR—uterine fibroid	0.0016	0.00412	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.0016	0.0041	CbGpPWpGaD
Regorafenib—FGFR1—DAP12 interactions—TNRC6B—uterine fibroid	0.0016	0.0041	CbGpPWpGaD
Regorafenib—FGFR1—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.0016	0.0041	CbGpPWpGaD
Regorafenib—PDGFRA—DAP12 interactions—TNRC6B—uterine fibroid	0.00159	0.00409	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00159	0.00409	CbGpPWpGaD
Regorafenib—PDGFRA—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00159	0.00409	CbGpPWpGaD
Regorafenib—ABL1—Regulation of Telomerase—ESR1—uterine fibroid	0.00159	0.00408	CbGpPWpGaD
Regorafenib—FGFR2—B Cell Activation—TNRC6B—uterine fibroid	0.00158	0.00408	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by EGFR—TNRC6B—uterine fibroid	0.00158	0.00407	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by EGFR—TNRC6B—uterine fibroid	0.00158	0.00406	CbGpPWpGaD
Regorafenib—CYP2B6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00157	0.00405	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00157	0.00403	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00156	0.00402	CbGpPWpGaD
Regorafenib—NTRK1—Signaling by NGF—TNRC6B—uterine fibroid	0.00156	0.00402	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by PDGF—TNRC6B—uterine fibroid	0.00156	0.00401	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by PDGF—TNRC6B—uterine fibroid	0.00156	0.004	CbGpPWpGaD
Regorafenib—KIT—B Cell Activation—TNRC6B—uterine fibroid	0.00156	0.004	CbGpPWpGaD
Regorafenib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—uterine fibroid	0.00155	0.00398	CbGpPWpGaD
Regorafenib—PDGFRB—Downstream signal transduction—TNRC6B—uterine fibroid	0.00155	0.00398	CbGpPWpGaD
Regorafenib—ABCG2—decidua—uterine fibroid	0.00154	0.00253	CbGeAlD
Regorafenib—PDGFRB—Signaling by FGFR—TNRC6B—uterine fibroid	0.00154	0.00396	CbGpPWpGaD
Regorafenib—RAF1—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00153	0.00394	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00153	0.00394	CbGpPWpGaD
Regorafenib—PDGFRB—DAP12 signaling—TNRC6B—uterine fibroid	0.00152	0.00392	CbGpPWpGaD
Regorafenib—FGFR2—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00152	0.0039	CbGpPWpGaD
Regorafenib—CYP2C8—endometrium—uterine fibroid	0.00151	0.00247	CbGeAlD
Regorafenib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.0015	0.00386	CbGpPWpGaD
Regorafenib—KIT—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00149	0.00383	CbGpPWpGaD
Regorafenib—ABCG2—urethra—uterine fibroid	0.00149	0.00244	CbGeAlD
Regorafenib—FGFR1—B Cell Activation—TNRC6B—uterine fibroid	0.00148	0.0038	CbGpPWpGaD
Regorafenib—PDGFRA—B Cell Activation—TNRC6B—uterine fibroid	0.00147	0.00379	CbGpPWpGaD
Regorafenib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00147	0.00377	CbGpPWpGaD
Regorafenib—RAF1—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00147	0.00377	CbGpPWpGaD
Regorafenib—ABCG2—endometrium—uterine fibroid	0.00147	0.0024	CbGeAlD
Regorafenib—CYP2C19—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00145	0.00372	CbGpPWpGaD
Regorafenib—RAF1—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00144	0.00371	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00143	0.00369	CbGpPWpGaD
Regorafenib—PDGFRB—DAP12 interactions—TNRC6B—uterine fibroid	0.00143	0.00369	CbGpPWpGaD
Regorafenib—PDGFRB—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00143	0.00369	CbGpPWpGaD
Regorafenib—RAF1—Signaling by ERBB4—PGR—uterine fibroid	0.00143	0.00368	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by EGFR—TNRC6B—uterine fibroid	0.00142	0.00366	CbGpPWpGaD
Regorafenib—ABCG2—mammalian vulva—uterine fibroid	0.00142	0.00232	CbGeAlD
Regorafenib—FGFR1—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00141	0.00364	CbGpPWpGaD
Regorafenib—PDGFRA—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00141	0.00363	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00141	0.00362	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by PDGF—TNRC6B—uterine fibroid	0.0014	0.00361	CbGpPWpGaD
Regorafenib—RAF1—Downstream signal transduction—TNRC6B—uterine fibroid	0.00138	0.00355	CbGpPWpGaD
Regorafenib—RAF1—Signaling by FGFR—TNRC6B—uterine fibroid	0.00137	0.00353	CbGpPWpGaD
Regorafenib—RAF1—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00137	0.00351	CbGpPWpGaD
Regorafenib—RAF1—DAP12 signaling—TNRC6B—uterine fibroid	0.00136	0.00349	CbGpPWpGaD
Regorafenib—MAPK11—Cellular responses to stress—TNRC6B—uterine fibroid	0.00135	0.00348	CbGpPWpGaD
Regorafenib—ABCG2—uterus—uterine fibroid	0.00135	0.00221	CbGeAlD
Regorafenib—UGT1A9—Biological oxidations—CYP17A1—uterine fibroid	0.00134	0.00346	CbGpPWpGaD
Regorafenib—UGT1A1—Biological oxidations—CYP17A1—uterine fibroid	0.00134	0.00346	CbGpPWpGaD
Regorafenib—RAF1—Leptin signaling pathway—ESR1—uterine fibroid	0.00134	0.00345	CbGpPWpGaD
Regorafenib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00134	0.00344	CbGpPWpGaD
Regorafenib—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00133	0.00343	CbGpPWpGaD
Regorafenib—PDGFRB—B Cell Activation—TNRC6B—uterine fibroid	0.00133	0.00341	CbGpPWpGaD
Regorafenib—UGT1A1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00133	0.00341	CbGpPWpGaD
Regorafenib—UGT1A9—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00133	0.00341	CbGpPWpGaD
Regorafenib—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00132	0.0034	CbGpPWpGaD
Regorafenib—CYP2C19—vagina—uterine fibroid	0.00129	0.00212	CbGeAlD
Regorafenib—RAF1—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00128	0.00329	CbGpPWpGaD
Regorafenib—RAF1—DAP12 interactions—TNRC6B—uterine fibroid	0.00128	0.00329	CbGpPWpGaD
Regorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00128	0.00329	CbGpPWpGaD
Regorafenib—MAPK11—Signaling by NGF—TNRC6B—uterine fibroid	0.00127	0.00327	CbGpPWpGaD
Regorafenib—PDGFRB—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00127	0.00327	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR—TNRC6B—uterine fibroid	0.00127	0.00326	CbGpPWpGaD
Regorafenib—BRAF—Signaling by NGF—TNRC6B—uterine fibroid	0.00126	0.00324	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00126	0.00323	CbGpPWpGaD
Regorafenib—RAF1—Signaling by PDGF—TNRC6B—uterine fibroid	0.00125	0.00321	CbGpPWpGaD
Regorafenib—CYP2C8—female reproductive system—uterine fibroid	0.00125	0.00204	CbGeAlD
Regorafenib—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00119	0.00306	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—TNRC6B—uterine fibroid	0.00117	0.003	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—TNRC6B—uterine fibroid	0.00115	0.00295	CbGpPWpGaD
Regorafenib—NTRK1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.00114	0.00294	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—MED12—uterine fibroid	0.00114	0.00293	CbGpPWpGaD
Regorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00113	0.00291	CbGpPWpGaD
Regorafenib—CYP2C8—vagina—uterine fibroid	0.00113	0.00185	CbGeAlD
Regorafenib—CYP2B6—female reproductive system—uterine fibroid	0.00112	0.00183	CbGeAlD
Regorafenib—CYP2C9—female reproductive system—uterine fibroid	0.00111	0.00182	CbGeAlD
Regorafenib—BRAF—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.00111	0.00285	CbGpPWpGaD
Regorafenib—ABCG2—female gonad—uterine fibroid	0.0011	0.00181	CbGeAlD
Regorafenib—ABCG2—vagina—uterine fibroid	0.0011	0.0018	CbGeAlD
Regorafenib—FGFR1—Signaling by NGF—TNRC6B—uterine fibroid	0.00109	0.0028	CbGpPWpGaD
Regorafenib—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00108	0.00279	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—TNRC6B—uterine fibroid	0.00108	0.00279	CbGpPWpGaD
Regorafenib—BRAF—Disease—HPSE2—uterine fibroid	0.00108	0.00277	CbGpPWpGaD
Regorafenib—ABCB1—myometrium—uterine fibroid	0.00103	0.00168	CbGeAlD
Regorafenib—FGFR2—Signaling by ERBB4—ESR1—uterine fibroid	0.00102	0.00263	CbGpPWpGaD
Regorafenib—CYP2B6—vagina—uterine fibroid	0.00101	0.00166	CbGeAlD
Regorafenib—KIT—Signaling by ERBB4—ESR1—uterine fibroid	0.001	0.00258	CbGpPWpGaD
Regorafenib—FGFR2—Disease—HPSE2—uterine fibroid	0.000998	0.00257	CbGpPWpGaD
Regorafenib—KIT—Disease—HPSE2—uterine fibroid	0.00098	0.00252	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—MED12—uterine fibroid	0.00098	0.00252	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—TNRC6B—uterine fibroid	0.000977	0.00251	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by ERBB4—ESR1—uterine fibroid	0.000953	0.00245	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by ERBB4—ESR1—uterine fibroid	0.000951	0.00244	CbGpPWpGaD
Regorafenib—FGFR1—Disease—HPSE2—uterine fibroid	0.00093	0.00239	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—MED12—uterine fibroid	0.000928	0.00239	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—HPSE2—uterine fibroid	0.000928	0.00239	CbGpPWpGaD
Regorafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000883	0.00227	CbGpPWpGaD
Regorafenib—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000871	0.00224	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—TNRC6B—uterine fibroid	0.000871	0.00224	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by ERBB4—ESR1—uterine fibroid	0.000856	0.0022	CbGpPWpGaD
Regorafenib—CYP3A4—female reproductive system—uterine fibroid	0.000846	0.00138	CbGeAlD
Regorafenib—ABL1—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000839	0.00216	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—MED12—uterine fibroid	0.000839	0.00216	CbGpPWpGaD
Regorafenib—CYP2B6—Biological oxidations—CYP17A1—uterine fibroid	0.000836	0.00215	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—HPSE2—uterine fibroid	0.000836	0.00215	CbGpPWpGaD
Regorafenib—CYP2B6—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000825	0.00212	CbGpPWpGaD
Regorafenib—ABCB1—uterine cervix—uterine fibroid	0.000799	0.00131	CbGeAlD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000794	0.00204	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000792	0.00204	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—CYP17A1—uterine fibroid	0.000777	0.002	CbGpPWpGaD
Regorafenib—RAF1—Signaling by ERBB4—ESR1—uterine fibroid	0.000763	0.00196	CbGpPWpGaD
Regorafenib—ABCB1—decidua—uterine fibroid	0.000761	0.00125	CbGeAlD
Regorafenib—RAF1—Disease—HPSE2—uterine fibroid	0.000745	0.00192	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—MED12—uterine fibroid	0.000735	0.00189	CbGpPWpGaD
Regorafenib—ABCB1—urethra—uterine fibroid	0.000734	0.0012	CbGeAlD
Regorafenib—MAPK11—Innate Immune System—TNRC6B—uterine fibroid	0.000725	0.00186	CbGpPWpGaD
Regorafenib—ABCB1—endometrium—uterine fibroid	0.000723	0.00118	CbGeAlD
Regorafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000715	0.00184	CbGpPWpGaD
Regorafenib—CYP2C8—Biological oxidations—CYP17A1—uterine fibroid	0.000708	0.00182	CbGpPWpGaD
Regorafenib—ABCB1—mammalian vulva—uterine fibroid	0.000699	0.00114	CbGeAlD
Regorafenib—CYP2C8—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000698	0.0018	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000695	0.00179	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—MED12—uterine fibroid	0.000672	0.00173	CbGpPWpGaD
Regorafenib—ABCB1—uterus—uterine fibroid	0.000666	0.00109	CbGeAlD
Regorafenib—FGFR2—Innate Immune System—TNRC6B—uterine fibroid	0.000665	0.00171	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—TNRC6B—uterine fibroid	0.000653	0.00168	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—HPSE2—uterine fibroid	0.000642	0.00165	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—HPSE2—uterine fibroid	0.000642	0.00165	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—TNRC6B—uterine fibroid	0.000639	0.00164	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—TNRC6B—uterine fibroid	0.000639	0.00164	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000636	0.00163	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—PGR—uterine fibroid	0.000633	0.00163	CbGpPWpGaD
Regorafenib—CYP2C19—Biological oxidations—CYP17A1—uterine fibroid	0.000632	0.00163	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—TNRC6B—uterine fibroid	0.000628	0.00161	CbGpPWpGaD
Regorafenib—CYP2C19—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000623	0.0016	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—TNRC6B—uterine fibroid	0.00062	0.00159	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—TNRC6B—uterine fibroid	0.000619	0.00159	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000617	0.00159	CbGpPWpGaD
Regorafenib—ABCB1—female reproductive system—uterine fibroid	0.000599	0.00098	CbGeAlD
Regorafenib—FGFR1—Adaptive Immune System—TNRC6B—uterine fibroid	0.000596	0.00153	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—TNRC6B—uterine fibroid	0.000594	0.00153	CbGpPWpGaD
Regorafenib—CYP2C9—Biological oxidations—CYP17A1—uterine fibroid	0.000576	0.00148	CbGpPWpGaD
Regorafenib—CYP2C9—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000568	0.00146	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—TNRC6B—uterine fibroid	0.000557	0.00143	CbGpPWpGaD
Regorafenib—ABCB1—female gonad—uterine fibroid	0.000545	0.000892	CbGeAlD
Regorafenib—ABCG2—Metabolism—HPSE2—uterine fibroid	0.000544	0.0014	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—TNRC6B—uterine fibroid	0.000543	0.0014	CbGpPWpGaD
Regorafenib—ABCB1—vagina—uterine fibroid	0.000542	0.000886	CbGeAlD
Regorafenib—PDGFRB—Adaptive Immune System—TNRC6B—uterine fibroid	0.000535	0.00138	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000516	0.00133	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—MED12—uterine fibroid	0.000501	0.00129	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—TNRC6B—uterine fibroid	0.000497	0.00128	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TNRC6B—uterine fibroid	0.000477	0.00123	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—TNRC6B—uterine fibroid	0.000477	0.00123	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—PGR—uterine fibroid	0.000472	0.00121	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—TNRC6B—uterine fibroid	0.000422	0.00109	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—TNRC6B—uterine fibroid	0.00042	0.00108	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—PGR—uterine fibroid	0.000416	0.00107	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—HPSE2—uterine fibroid	0.000399	0.00103	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—TNRC6B—uterine fibroid	0.000388	0.000997	CbGpPWpGaD
Regorafenib—BRAF—Disease—TNRC6B—uterine fibroid	0.000386	0.000993	CbGpPWpGaD
Regorafenib—KIT—Immune System—TNRC6B—uterine fibroid	0.000381	0.000979	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	0.00038	0.000977	CbGpPWpGaD
Regorafenib—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000375	0.000964	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—TNRC6B—uterine fibroid	0.000361	0.000929	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—TNRC6B—uterine fibroid	0.00036	0.000926	CbGpPWpGaD
Regorafenib—FGFR2—Disease—TNRC6B—uterine fibroid	0.000358	0.00092	CbGpPWpGaD
Regorafenib—KIT—Disease—TNRC6B—uterine fibroid	0.000351	0.000904	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—ESR1—uterine fibroid	0.000338	0.000869	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—HPSE2—uterine fibroid	0.000338	0.000869	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TNRC6B—uterine fibroid	0.000336	0.000864	CbGpPWpGaD
Regorafenib—FGFR1—Disease—TNRC6B—uterine fibroid	0.000334	0.000858	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—TNRC6B—uterine fibroid	0.000333	0.000855	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PGR—uterine fibroid	0.000332	0.000855	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000325	0.000835	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—TNRC6B—uterine fibroid	0.000325	0.000835	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TNRC6B—uterine fibroid	0.000317	0.000816	CbGpPWpGaD
Regorafenib—ABL1—Immune System—TNRC6B—uterine fibroid	0.000316	0.000813	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PGR—uterine fibroid	0.000314	0.000808	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—HPSE2—uterine fibroid	0.000302	0.000775	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.0003	0.000771	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—TNRC6B—uterine fibroid	0.0003	0.000771	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—HPSE2—uterine fibroid	0.000294	0.000757	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.00029	0.000746	CbGpPWpGaD
Regorafenib—RAF1—Immune System—TNRC6B—uterine fibroid	0.000289	0.000744	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—HPSE2—uterine fibroid	0.000275	0.000707	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—MED12—uterine fibroid	0.000275	0.000706	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—MED12—uterine fibroid	0.000275	0.000706	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TNRC6B—uterine fibroid	0.000273	0.000702	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000272	0.000699	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TNRC6B—uterine fibroid	0.00027	0.000695	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PGR—uterine fibroid	0.00027	0.000695	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PGR—uterine fibroid	0.000268	0.000688	CbGpPWpGaD
Regorafenib—RAF1—Disease—TNRC6B—uterine fibroid	0.000267	0.000687	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000264	0.00068	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—ESR1—uterine fibroid	0.000252	0.000648	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TNRC6B—uterine fibroid	0.000251	0.000644	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PGR—uterine fibroid	0.000248	0.000638	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TNRC6B—uterine fibroid	0.000246	0.000633	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PGR—uterine fibroid	0.000244	0.000626	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000243	0.000624	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TNRC6B—uterine fibroid	0.000234	0.000601	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—MED12—uterine fibroid	0.000233	0.000599	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TNRC6B—uterine fibroid	0.000233	0.000599	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PGR—uterine fibroid	0.000231	0.000595	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PGR—uterine fibroid	0.000231	0.000593	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CYP17A1—uterine fibroid	0.00023	0.000591	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CYP17A1—uterine fibroid	0.00023	0.000591	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—ESR1—uterine fibroid	0.000222	0.000571	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000221	0.000569	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TNRC6B—uterine fibroid	0.00021	0.00054	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PGR—uterine fibroid	0.000208	0.000534	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CYP17A1—uterine fibroid	0.000195	0.000502	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TNRC6B—uterine fibroid	0.000187	0.000481	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PGR—uterine fibroid	0.000185	0.000476	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—HPSE2—uterine fibroid	0.000181	0.000466	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—ESR1—uterine fibroid	0.000178	0.000456	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—MED12—uterine fibroid	0.000171	0.000439	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—ESR1—uterine fibroid	0.000168	0.000431	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MED12—uterine fibroid	0.000145	0.000372	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—ESR1—uterine fibroid	0.000144	0.000371	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CYP17A1—uterine fibroid	0.000143	0.000368	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—ESR1—uterine fibroid	0.000143	0.000367	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—ESR1—uterine fibroid	0.000132	0.000341	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—ESR1—uterine fibroid	0.00013	0.000334	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MED12—uterine fibroid	0.000129	0.000332	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MED12—uterine fibroid	0.000126	0.000324	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—ESR1—uterine fibroid	0.000123	0.000317	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—ESR1—uterine fibroid	0.000123	0.000317	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CYP17A1—uterine fibroid	0.000121	0.000311	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MED12—uterine fibroid	0.000118	0.000303	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—ESR1—uterine fibroid	0.000111	0.000285	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CYP17A1—uterine fibroid	0.000108	0.000278	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CYP17A1—uterine fibroid	0.000105	0.000271	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—ESR1—uterine fibroid	9.89e-05	0.000254	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CYP17A1—uterine fibroid	9.85e-05	0.000253	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MED12—uterine fibroid	7.76e-05	0.0002	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYP17A1—uterine fibroid	6.5e-05	0.000167	CbGpPWpGaD
